Login

Consolidated Statements of Financial Position

In millions of USD, except per-share amounts
Q4 FY2022
As of Jun 30, 2023
Q4 FY2021
As of Jul 13, 2022
Assets
Cash and cash equivalents
Accounts receivable - external parties
Accounts receivable
Related parties
External parties
Inventory
Prepaid expenses
Deposits
Total current assets
Property, plant and equipment, net
Operating lease right of use assets, net
Total non-current assets
Total assets
Liabilities and Shareholders' Deficit
Accounts Payable
Transaction and offer related fees
Borrowings
Related party borrowings
Contract liabilities
Employee benefits
Other provisions
Obligations under operating leases
Financial instruments - derivative
Other current liabilities
Warrants
Total current liabilities
Total non-current liabilities
Total liabilities
Shareholders' Deficit
Common stock, no par value, unlimited stock authorized at June 30, 2023, 160,036,639 shares issued (153,094,269 as of June 30, 2022); 142,007,286 shares outstanding as of June 30, 2023 (148,893,898 as of June 30, 2022)
Treasury shares, 3,015,188 as of June 30, 2023 (4,200,371 as of June 30, 2022)
Additional paid in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total Shareholders' deficit
Total Liabilities, and Shareholders' deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support